Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/05fe116e-1bc3-4e6b-bab3-7e07b39ae2c0/

AUROPHARMA

Aurobindo Pharma Limited
Chart
₹1,462.30
Latest Week 2026-06-05
HealthcareDrug Manufacturers - Specialty & GenericMEGA
Snapshot 2026-06-07 · 0.0w · Fresh
0.94
OS Score
71.0%
Value
84.0%
Quality
87.0%
Momentum
6/9
F-Score
0.772
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
8 of 23 passing
★
OS Composite
OS 0.940
↗
Trending Value
✗
◆
Quality × Value
QV 0.772
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
8.6%
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
Noneyr
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
12-1 29%
◉
Market Leaders
Yes
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
Vol 24%
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
RAM 1.19
V
Value Analysis
Cheapness relative to fundamentals
71.0%ile
P/E
23.9×
P/S
2.5×
P/B
2.2×
E/P
0.0419
FCF Yield
0.028
EBITDA/EV
0.086
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
32.00000000
/100 — 1=cheapest
VC2 (Trending Value)
33.00000000
/100
VC3 (Buyback)
27.00000000
/100
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
84.0%ile
ROE
0.094
ROA
0.061
Net Margin
0.106
Op Margin
0.154
GPA
0.341
Current
1.81
F-Score
6/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.064
Earn Growth
0.005
Stability
0.049
lower=better
Accruals
-0.034
lower=better
5yr Consist
Yes
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
87.0%ile
6M Return
20.1%
12M Return
26.4%
12-1 Mom
28.6%
Risk-Adj
1.19
Vol 252d
24.0%
Vol 60d
49.7%
↑ Expanding
Max DD 12M
-13.4%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 29% is very strong — a clear uptrend. Near-term vol (50%) is expanding vs long-term (24%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.94
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 160 peers
Sector Value %ile
90.7%
Sector Quality %ile
72.7%
P/E z-score
-0.21
P/B z-score
-0.68
Sector Avg OS
43.4%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
NATCOPHARM NATCO Pharma Limited 98.0% 88.0% 87.0% 81.0%
UNIVPHOTO Universus Photo Imagings Limited 97.0% 86.0% 74.0% 94.0%
LINCOLN Lincoln Pharmaceuticals Limited 97.0% 88.0% 80.0% 81.0%
VENUSREM Venus Remedies Limited 96.0% 68.0% 94.0% 99.0%
STAR Strides Pharma Science Limited 96.0% 73.0% 91.0% 91.0%
HALEOSLABS Haleos Labs Limited 95.0% 82.0% 77.0% 81.0%
SAGILITY Sagility Limited 93.0% 76.0% 81.0% 76.0%
LUPIN Lupin Limited 93.0% 64.0% 98.0% 82.0%
Factor Interactions
Value + Quality Intersection
Top-tier on both cheapness (71th) and quality (84th) — the O'Shaughnessy sweet spot, historically the strongest long-term combination.
Trending Value Signal
Cheap (71th value) with strong momentum (87th). The market is starting to recognise the value.
Volatility Expanding
60-day vol (50%) significantly exceeds 252-day (24%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
C
48.0% avg (7 factors)
Quality
C
51.7% avg (7 factors)
Momentum
B
62.9% avg (4 factors)
Risk
A
76.7% avg (1 factors)
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.940—1—
Value %ile0.710—1—
Quality %ile0.840—1—
Momentum %ile0.870—1—
F-Score6.000—0—
Confidence0.939—1—
Volatility0.240—0—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
23.86
Earnings Yield (E/P)
0.0419
Price / Sales
2.53
Price / Book
2.24
Price / Cash Flow
15.37
FCF Yield
2.8%
EBITDA / EV
8.6%
Sales Yield (1/P·S)
0.3907
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
9.4%
Return on Assets
6.1%
Net Margin
10.6%
Operating Margin
15.4%
Gross Profit / Assets
Novy-Marx GPA
34.1%
Current Ratio
1.81
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.034
MomentumPrice trend strength over different horizons
6M Return
20.1%
12M Return
26.4%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
28.6%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
1.19
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
6.4%
Earnings Growth (YoY)
0.5%
Earnings Stability (CV)
Lower = more stable
0.049
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
6
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
32
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
33
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
27
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
Yes
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity